![Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers Patel RS, Sharma KH, Kamath NA, Patel NH, Thakkar AM - Indian J Pharmacol Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers Patel RS, Sharma KH, Kamath NA, Patel NH, Thakkar AM - Indian J Pharmacol](https://www.ijp-online.com/articles/2014/46/5/images/Indian%20J%20Pharmacol_2014_46_5_485_140577_t4.jpg)
Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers Patel RS, Sharma KH, Kamath NA, Patel NH, Thakkar AM - Indian J Pharmacol
![Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/67c0797707e78e220989e461b8072db79ed1fb0a/5-Table1-1.png)
Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar
![Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/756f1a156300486fff78e90803b94ee14c5b9b76/7-Table5-1.png)
Table 5 from Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). | Semantic Scholar
![Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial | Semantic Scholar Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/91fe0292f4ac6e62b247a156b06280b9a441603d/5-Table3-1.png)
Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial | Semantic Scholar
![Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914912024642-gr4.jpg)
Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect
![Vernakalant: Conversion of atrial fibrillation in patients with ischemic heart disease - International Journal of Cardiology Vernakalant: Conversion of atrial fibrillation in patients with ischemic heart disease - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e408b61d-a4fc-49e0-9a4b-2c465aefe98d/gr2_lrg.jpg)
Vernakalant: Conversion of atrial fibrillation in patients with ischemic heart disease - International Journal of Cardiology
![Metoprolol better than atenolol in therapy of cardiac failure! Role of peripheral NPY!? | Bengtablad's Blog Metoprolol better than atenolol in therapy of cardiac failure! Role of peripheral NPY!? | Bengtablad's Blog](https://bengtablad.files.wordpress.com/2012/01/table_1-01.png)
Metoprolol better than atenolol in therapy of cardiac failure! Role of peripheral NPY!? | Bengtablad's Blog
![Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database - Paolillo - 2017 - European Journal of Heart Failure - Wiley Online Library Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database - Paolillo - 2017 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8a572601-cb6a-4b2b-ad49-fd6a1312330e/ejhf775-fig-0003-m.jpg)
Prognostic role of β‐blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database - Paolillo - 2017 - European Journal of Heart Failure - Wiley Online Library
![Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914912024642-gr2.jpg)